Verition Fund Management LLC reduced its holdings in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 99.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,785 shares of the health services provider's stock after selling 5,246,451 shares during the quarter. Verition Fund Management LLC's holdings in Teladoc Health were worth $201,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Kinnevik AB publ acquired a new position in shares of Teladoc Health during the fourth quarter worth approximately $458,235,000. ARK Investment Management LLC raised its stake in Teladoc Health by 2.9% during the 1st quarter. ARK Investment Management LLC now owns 19,466,931 shares of the health services provider's stock valued at $1,404,150,000 after purchasing an additional 544,733 shares during the last quarter. Greenhaven Road Investment Management L.P. bought a new stake in Teladoc Health in the 4th quarter valued at $27,546,000. Marshall Wace LLP grew its position in Teladoc Health by 70.2% in the 4th quarter. Marshall Wace LLP now owns 438,030 shares of the health services provider's stock worth $40,219,000 after purchasing an additional 180,654 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new stake in shares of Teladoc Health in the first quarter valued at about $11,437,000. 92.46% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on TDOC shares. Bank of America raised their price objective on Teladoc Health from $36.00 to $42.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 6th. Stifel Nicolaus decreased their price target on shares of Teladoc Health from $36.00 to $30.00 in a research note on Thursday, July 28th. Barclays dropped their price objective on shares of Teladoc Health from $45.00 to $42.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 20th. Needham & Company LLC lowered shares of Teladoc Health from a "buy" rating to a "hold" rating in a research report on Thursday, July 28th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of Teladoc Health from $44.00 to $34.00 in a research report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, twenty-four have assigned a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Teladoc Health has an average rating of "Hold" and a consensus target price of $66.88.

Teladoc Health Price Performance

Teladoc Health (NYSE:TDOC – Get Rating) last released its quarterly earnings data on Wednesday, July 27th. The health services provider reported ($0.44) EPS for the quarter, beating analysts' consensus estimates of ($0.71) by $0.27. Teladoc Health had a negative return on equity of 2.04% and a negative net margin of 441.94%. The business had revenue of $592.38 million during the quarter, compared to the consensus estimate of $586.86 million. As a group, analysts anticipate that Teladoc Health, Inc. will post -1.54 earnings per share for the current year.

Insider Buying and Selling

In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the company's stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $37.50, for a total value of $37,500.00. Following the completion of the sale, the senior vice president now owns 26,408 shares of the company's stock, valued at $990,300. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the completion of the sale, the senior vice president now directly owns 26,408 shares in the company, valued at $990,300. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Arnnon Geshuri sold 4,098 shares of the business's stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the completion of the transaction, the insider now owns 76,182 shares of the company's stock, valued at $2,610,757.14. The disclosure for this sale can be found here. Insiders have sold 7,318 shares of company stock valued at $255,321 in the last 90 days. 1.55% of the stock is owned by insiders.

About Teladoc Health

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Recommended Stories

• Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
• MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
• Is the Market Overreacting with Shopify Stock?
• MO Money: Why Altria Group Stock is Rallying
• Fed Raises Rates: 3 Stocks to Watch Newmont Mining, Walmart, AMC
• Three Consumer Stocks That Could Outperform In Q4

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.